Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd.verified

GLMD

Price:

$0.612

Market Cap:

$3.35M

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for liver diseases. Its primary pipeline candidate is Aramchol, an orally administered drug currently undergoing Phase III clinical trials. This pivotal study is for the treatment of non-alcoholic steato-hepatitis (NASH) in individuals who are overweight or obese and also present with pre-diabetes or type 2 diabetes. Aramchol is also being investigated in the Phase IIa ARRIVE Study, which targets HIV-associated non-alcoholic fatty liver disease and lipodystrophy. Beyond Aramchol, the company is developing Amilo-5MER, a synthetic peptide composed of five specific amino acids: methionine, t...[Read more]

Industry

Biotechnology

IPO Date

2014-03-13

Stock Exchange

NASDAQ

Ticker

GLMD

The Current Ratio as of June 2026 (TTM) for Galmed Pharmaceuticals Ltd. (GLMD) is 6.55

According to Galmed Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 6.55. This represents a change of -18.80% compared to the average of 8.06 of the last 4 quarters.

Galmed Pharmaceuticals Ltd. (GLMD) Historical Current Ratio (quarterly & annually)

How has GLMD Current Ratio performed in the past?

The mean historical Current Ratio of Galmed Pharmaceuticals Ltd. over the last ten years is 8.90. The current 6.55 Current Ratio has changed 7.26% with respect to the historical average. Over the past ten years (40 quarters), GLMD's Current Ratio was at its highest in in the September 2018 quarter at 43.29. The Current Ratio was at its lowest in in the June 2017 quarter at 2.59.

Quarterly (TTM)
Annual

Average

8.90

Median

6.30

Minimum

3.44

Maximum

33.41

Galmed Pharmaceuticals Ltd. (GLMD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Galmed Pharmaceuticals Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 571.26%

Maximum Annual Current Ratio = 33.41

Minimum Annual Increase = -67.01%

Minimum Annual Current Ratio = 3.44

Quarterly (TTM)
Annual
YearCurrent RatioChange
20256.55-11.76%
20247.4254.13%
20234.811.16%
20224.76-22.40%
20216.13-5.16%
20206.47-41.33%
201911.02-67.01%
201833.41571.26%
20174.9844.87%
20163.44-62.66%

Galmed Pharmaceuticals Ltd. (GLMD) Average Current Ratio

How has GLMD Current Ratio performed in the past?

The current Current Ratio of Galmed Pharmaceuticals Ltd. (GLMD) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

6.26

5-year avg

5.93

10-year avg

8.90

Galmed Pharmaceuticals Ltd. (GLMD) Current Ratio vs. Peers

How is GLMD’s Current Ratio compared to its peers?

Galmed Pharmaceuticals Ltd.’s Current Ratio is less than BioVie Inc. (9.97), greater than Theriva Biologics, Inc. (1.63), greater than Moolec Science S.A. (0.13), less than Chemomab Therapeutics Ltd. (10.31), greater than InMed Pharmaceuticals Inc. (3.11), greater than Biodexa Pharmaceuticals Plc (2.03), less than Virax Biolabs Group Limited (11.35), greater than PMGC Holdings Inc. (1.45), greater than iSpecimen Inc. (0.62), greater than NKGen Biotech, Inc. Common Stock (0.05),

Build a custom stock screener for Galmed Pharmaceuticals Ltd. (GLMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galmed Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galmed Pharmaceuticals Ltd. (GLMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galmed Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Galmed Pharmaceuticals Ltd.'s Current Ratio?

How is the Current Ratio calculated for Galmed Pharmaceuticals Ltd. (GLMD)?

What is the highest Current Ratio for Galmed Pharmaceuticals Ltd. (GLMD)?

What is the 3-year average Current Ratio for Galmed Pharmaceuticals Ltd. (GLMD)?

What is the 5-year average Current Ratio for Galmed Pharmaceuticals Ltd. (GLMD)?

How does the current Current Ratio for Galmed Pharmaceuticals Ltd. (GLMD) compare to its historical average?